CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90,089 enrolled
Drug / intervention
inhaled corticosteroid therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02714283
NCT02714283N/ACompleted
CompareCT.gov

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

Oregon Health and Science University·observational·Posted Mar 21, 2016·Updated Sep 18, 2019

In Brief

An observational study evaluating inhaled corticosteroid therapy and macrolide therapy for Bronchiectasis. Completed, enrolled 90,089 participants.

Detailed Summary

The purpose of this study is to provide patients and their physicians with greater understanding of the risks and benefits of commonly used therapies for treatment of non-CF bronchiectasis

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiectasis
Countries--
CollaboratorsPatient-Centered Outcomes Research Institute, University of Alabama at Birmingham, National Jewish Health, COPD Foundation

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 21, 2016
Enrollment StartOct 28, 2016
Primary CompletionJun 30, 2018
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 10.3 years ago

Interventions

inhaled corticosteroid therapydrug

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies

macrolide therapydrug

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies